Best practices in preventing heartbreak:

A look at a SWOG cancer control trial

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The development of more effective cancer treatment has yielded higher cure rates, longer survival, and a decrease in cancer recurrence. As of January 2019, the National Cancer Institute estimated that there were 16.9 million cancer survivors in the United States. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Justin Floyd, DO, FACOI
Medical oncologist, Cancer Care Specialists of Illinois, Heartland NCORP
Monika Leja, MD
Clinical assistant professor, Frankel Cardiovascular Center, University of Michigan
Table of Contents

YOU MAY BE INTERESTED IN

Justin Floyd, DO, FACOI
Medical oncologist, Cancer Care Specialists of Illinois, Heartland NCORP
Monika Leja, MD
Clinical assistant professor, Frankel Cardiovascular Center, University of Michigan

Login